David S Klimstra

7PUBLICATIONS
87CO-AUTHORS
Molecular targetsBiomedical imagingOncology and carcinogenesis not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 01, 2026
MET expression by immunohistochemistry as a biomarker in pancreatic neuroendocrine tumours.

|Aug 06, 2024
A Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms.

Fresia Pareja, Higinio Dopeso, Yi Kan Wang

|Mar 16, 2022
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.

Guido Rindi, Ozgur Mete, Silvia Uccella

|Jan 11, 2022
Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma.

Maryam Pourmaleki, Caitlin J Jones, Charlotte E Ariyan

|Jun 17, 2021
Quantitative Computed Tomography Image Analysis to Predict Pancreatic Neuroendocrine Tumor Grade.

Alessandra Pulvirenti, Rikiya Yamashita, Jayasree Chakraborty

|Apr 23, 2020
Gastrointestinal tissue-based molecular biomarkers: a practical categorisation based on the 2019 World Health Organization classification of epithelial digestive tumours.

Javier I Quezada-Marín, Alfred K Lam, Atsushi Ochiai

Pageof 2

Frequent Collaborators

2 joint publications

Richard K G Do

1 joint publications

Felipe Carrasco-Tenezaca

1 joint publications

Leanne M Brown

1 joint publications

Guannan Gong